Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion
Home
Publications
Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion
Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion
Authors:
MG
Manuel González-Ortiz
Manuel González-Ortiz
MV
Miriam Méndez-Del Villar
Miriam Méndez-Del Villar
EM
Esperanza Martínez-Abundis
Esperanza Martínez-Abundis
AR
Alejandra M. Ramírez-Rodríguez
Alejandra M. Ramírez-Rodríguez
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 July 2018
journal article
research article
Published by
Edizioni Minerva Medica
in
Minerva Endocrinology
Vol. 43
(3)
,
229-235
DOI:
10.23736/s0391-1977.16.02550-5
PMID:
28001016
Abstract
Article: Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion - Minerva Endocrinologica 2018 September;43(3):229-35 - Minerva Medica - Journals
Keywords
2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL
METABOLIC SYNDROME X
INSULIN RESISTANCE
Related articles
Cited
Cited by 15 articles
Scroll to top